Erasca

Performance

About Erasca

Erasca is a clinical-stage biotechnology company focused on precision oncology. The company is dedicated to erasing cancer by targeting the RAS/MAPK signaling pathway, a frequently mutated route across multiple cancers. Its robust, modality-agnostic pipeline aims to shut down this pathway at various points to potentially benefit millions of patients worldwide. Erasca operates in the global cancer therapeutics space, developing targeted interventions with the goal of transforming cancer treatment outcomes.